Current Evidence and Clinical Trial Findings Phase 2 data published in the NEJM (2023) showed dose-dependent body weight reductions with retatrutide over 48 weeks, with gastrointestinal side effects being the most commonly reported
Front Hum Neurosci 15:648816 Hermens DF, Hatton SN, Lee RSC et al (2018) In vivo imaging of oxidative stress and fronto-limbic white matter integrity in young adults with mood disorders
Clinical management of acute diarrhoea: WHO/UNICEF joint statement
The information presented reflects research findings and community experiences, not established medical protocols
doi: 10.1128/AEM.00854-13 61 DolatkhahN.JafariA.EslamianF.ToopchizadehV.SalehP.HashemianM
This hormone helps regulate appetite and glucose, which can lead to reduced hunger, better insulin sensitivity, and gradual, consistent weight loss over time